Frontier Biotech and GSK Enter Global Exclusive Licensing Agreement for Small Interfering RNA Therapeutics
NANJING, China, Feb. 24, 2026 /PRNewswire/ — Frontier Biotechnologies Inc. (hereinafter referred to as “Frontier Biotech” or “the Company”) has entered into…
